Osteopetrosis
Gene: LEMD3
BOS is characterized by benign skeletal and cutaneous lesions. Variable expressivity has been reported and skin changes have onset in childhood while bone changes tend to develop after first decade.
Established gene-disease associationCreated: 28 Mar 2022, 4:12 a.m. | Last Modified: 28 Mar 2022, 4:12 a.m.
Panel Version: 0.13
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Buschke-Ollendorff syndrome MIM#166700; Osteopoikilosis with or without melorheostosis MIM#166700
Publications
Phenotypes for gene: LEMD3 were changed from Buschke-Ollendorff syndrome MIM#166700; Osteopoikilosis with or without melorheostosis MIM#166700 to Buschke-Ollendorff syndrome MIM#166700; Osteopoikilosis with or without melorheostosis MIM#166700
Gene: lemd3 has been classified as Green List (High Evidence).
Phenotypes for gene: LEMD3 were changed from to Buschke-Ollendorff syndrome MIM#166700; Osteopoikilosis with or without melorheostosis MIM#166700
Publications for gene: LEMD3 were set to
Mode of inheritance for gene: LEMD3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
gene: LEMD3 was added gene: LEMD3 was added to Osteopetrosis_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: LEMD3 was set to Unknown